🇺🇸 VTRS — Viatris Inc.

Healthcare
← Volver

Precio actual

16,88 USD

Máx. histórico

76,69

4151 días

Caída desde máximo

-77,99%

Rango 52 semanas

9,43 – 18,39

Variación hoy

-0,35%

Cierre anterior

16,94

Rango de hoy

16,67 – 17,02

Volumen hoy

5.599.203

Información
Nombre completo
Viatris Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - Specialty & Generic
Empleados
30.000
PER ⓘ
—
Dividend yield
2,83% (puede no estar actualizado)
Precio objetivo analistas
18,50 USD (puede no estar actualizado)
Primera cotización
17/03/1980
Precio actualizado
hace 1 día
Sobre la empresa

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Dividendos repartidos Total últimos 12 meses: 0,4800 USD · Yield: 2,84%
Fecha de pago Importe por participación
25/03/1994 0,0119 USD
27/12/1993 0,0119 USD
24/09/1993 0,0119 USD
24/06/1993 0,0089 USD
25/03/1993 0,0089 USD
24/12/1992 0,0089 USD
24/09/1992 0,0089 USD
24/06/1992 0,0074 USD
25/03/1992 0,0074 USD
24/12/1991 0,0074 USD
24/09/1991 0,0074 USD
24/06/1991 0,0074 USD
22/03/1991 0,0074 USD
24/12/1990 0,0074 USD
24/09/1990 0,0074 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/05/2022 11,05 11,24 10,98 11,14 +0,54% 2,35% 8.598.000
13/05/2022 10,83 11,15 10,79 11,08 +2,12% 3,32% 10.972.600
12/05/2022 10,41 10,88 10,38 10,85 +4,43% 4,80% 21.655.500
11/05/2022 10,43 10,74 10,37 10,39 -0,67% 3,55% 17.018.600
10/05/2022 10,38 10,55 10,14 10,46 -0,19% 3,95% 19.772.400
09/05/2022 10,13 10,94 10,13 10,48 +5,33% 8,00% 25.016.800
06/05/2022 10,04 10,05 9,76 9,95 -1,00% 2,89% 20.263.100
05/05/2022 10,45 10,50 9,88 10,05 -4,47% 5,93% 17.092.900
04/05/2022 10,39 10,53 10,07 10,52 +1,15% 4,43% 16.615.600
03/05/2022 10,24 10,46 10,12 10,40 +1,86% 3,32% 12.806.700
02/05/2022 10,35 10,45 10,03 10,21 -1,16% 4,06% 13.070.600
29/04/2022 10,45 10,61 10,27 10,33 -1,53% 3,25% 13.224.400
28/04/2022 10,38 10,54 10,26 10,49 +1,25% 2,70% 12.178.300
27/04/2022 10,32 10,49 10,18 10,36 +0,68% 3,00% 9.515.200
26/04/2022 10,32 10,50 10,25 10,29 -0,96% 2,42% 14.309.600
25/04/2022 10,23 10,45 10,02 10,39 +1,07% 4,20% 12.715.000
22/04/2022 10,68 10,68 10,27 10,28 -3,47% 3,84% 9.837.400
21/04/2022 10,88 10,99 10,62 10,65 -1,75% 3,40% 8.632.300
20/04/2022 10,88 11,02 10,74 10,84 -0,73% 2,57% 7.801.200
19/04/2022 10,72 11,00 10,67 10,92 +1,96% 3,08% 8.582.900
18/04/2022 10,94 10,98 10,64 10,71 -2,28% 3,11% 8.772.500
14/04/2022 10,99 11,12 10,94 10,96 -0,27% 1,64% 9.283.500
13/04/2022 10,71 11,03 10,67 10,99 +3,00% 3,36% 11.023.000
12/04/2022 10,72 10,80 10,63 10,67 -0,28% 1,59% 7.330.100
11/04/2022 11,00 11,02 10,64 10,70 -3,08% 3,45% 17.818.700
08/04/2022 10,80 11,10 10,62 11,04 +2,13% 4,44% 14.248.600
07/04/2022 10,66 10,85 10,52 10,81 +1,12% 3,10% 13.286.000
06/04/2022 10,58 10,71 10,48 10,69 +0,19% 2,17% 9.288.500
05/04/2022 10,78 11,03 10,66 10,67 -1,66% 3,43% 10.419.900
04/04/2022 10,82 11,02 10,76 10,85 +0,28% 2,40% 11.972.900